drugset / Trial / NCT06791772
Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy and safety of CM313(SC) injection in systemic lupus erythematosus(SLE)
Timeline
- Start
- 2025-02
- Primary completion
- 2026-10
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LUMROTATUG | Monoclonal antibody | 600 mg | Subcutaneous |
| Subject | LUMROTATUG | Monoclonal antibody | 1200 mg | Subcutaneous |